Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/30/2025 | $48.00 | Outperform | Mizuho |
6/25/2025 | $45.00 | Buy | Citigroup |
3/14/2025 | $45.00 | Buy | Truist |
2/11/2025 | $51.00 | Buy | Jefferies |
11/22/2024 | $40.00 | Outperform → Strong Buy | Raymond James |
7/2/2024 | $27.00 | Buy | BofA Securities |
7/2/2024 | $24.00 | Overweight | Barclays |
7/2/2024 | $27.00 | Buy | Deutsche Bank |
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b
Study finds AI is delivering double-digit gains in revenue cycle performance, becoming indispensable to healthcare providers' success LEHI, Utah and LOUISVILLE, Ky., June 23, 2025 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the results of a commissioned study conducted by Forrester Consulting on behalf of Waystar revealing that AI is becoming mission-critical in revenue cycle management (RCM) because of its proven impact and measurable return on investment. The study, "AI in Healthcare Payments Software: A Strategic
New directors bring deep expertise in AI innovation, healthcare, and enterprise growth LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the appointment of two accomplished leaders, Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman of the Board and Chief Executive Officer of 3M, to its Board of Directors. "We're honored to welcome Aashima and Mike to Waystar's Board," said Matt Hawkins
USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b
New directors bring deep expertise in AI innovation, healthcare, and enterprise growth LEHI, Utah and LOUISVILLE, Ky., June 16, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today announced the appointment of two accomplished leaders, Aashima Gupta, Global Director of Healthcare Strategy and Solutions at Google Cloud, and Michael Roman, former Executive Chairman of the Board and Chief Executive Officer of 3M, to its Board of Directors. "We're honored to welcome Aashima and Mike to Waystar's Board," said Matt Hawkins
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
4 - Waystar Holding Corp. (0001990354) (Issuer)
Mizuho initiated coverage of Waystar Holding Corp. with a rating of Outperform and set a new price target of $48.00
Citigroup initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
Truist initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $45.00
4 - Waystar Holding Corp. (0001990354) (Issuer)
144 - Waystar Holding Corp. (0001990354) (Subject)
8-K - Waystar Holding Corp. (0001990354) (Filer)
424B7 - Waystar Holding Corp. (0001990354) (Filer)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
SC 13G - Waystar Holding Corp. (0001990354) (Subject)
Q1 revenue growth of 14% year-over-year Q1 net income of $29.3 million and non-GAAP net income of $58.7 million Q1 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., April 30, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the first quarter ended March 31, 2025. "Waystar sustained strong momentum in the first quarter of 2025, delivering net income margins exceeding 10%, adjusted EBITDA margins excee
LEHI, Utah and LOUISVILLE, Ky., April 7, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the first quarter ended March 31, 2025, after market close on Wednesday, April 30, 2025. The company will discuss its financial results on a conference call at 4:30 p.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. The webcast will be arc
Fiscal year 2024 revenue of $944M, up 19% YoY Q4 revenue growth of 18% year-over-year Q4 net income of $19.1 million and non-GAAP net income of $52.1 million Fiscal year 2024 net loss $19.1 million, 62.7% improvement YoY Fiscal year 2024 adjusted EBITDA of $383M, up 15% YoY Q4 net income margin of 8%; adjusted EBITDA margin of 41% LEHI, Utah and LOUISVILLE, Ky., Feb. 18, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2024. "We are please